Xeptiva Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.8M
- Investors
-
8
Xeptiva Therapeutics General Information
Description
Developer of an immunotherapy platform designed to address chronic inflammatory conditions in companion animals. The company's platform offers active therapeutic vaccines for disorders such as osteoarthritis, atopic dermatitis, chronic pain, and obesity, enabling pet owners and veterinary professionals, to improve health span and lifespan through affordable and effective immune-based treatments.
Contact Information
Website
www.xeptiva.comCorporate Office
- Montevideo
- Uruguay
Corporate Office
- Montevideo
- Uruguay
Xeptiva Therapeutics Timeline
Xeptiva Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 30-Sep-2025 | $1.8M | Completed | Clinical Trials - General | ||
| 1. Seed Round | 08-Jul-2024 | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Xeptiva Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Xeptiva Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Xeptiva Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fen Ventures | Venture Capital | Minority | ||
| iThink VC | Venture Capital | Minority | ||
| NDLatam | Venture Capital | Minority | ||
| Seedstars International Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Xeptiva Therapeutics FAQs
-
When was Xeptiva Therapeutics founded?
Xeptiva Therapeutics was founded in 2021.
-
Where is Xeptiva Therapeutics headquartered?
Xeptiva Therapeutics is headquartered in Montevideo, Uruguay.
-
What is the size of Xeptiva Therapeutics?
Xeptiva Therapeutics has 11 total employees.
-
What industry is Xeptiva Therapeutics in?
Xeptiva Therapeutics’s primary industry is Other Commercial Services.
-
Is Xeptiva Therapeutics a private or public company?
Xeptiva Therapeutics is a Private company.
-
What is Xeptiva Therapeutics’s current revenue?
The current revenue for Xeptiva Therapeutics is .
-
How much funding has Xeptiva Therapeutics raised over time?
Xeptiva Therapeutics has raised $4.3M.
-
Who are Xeptiva Therapeutics’s investors?
Fen Ventures, iThink VC, NDLatam, Seedstars International Ventures, and are 5 of 8 investors who have invested in Xeptiva Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
